Novartis Financial Statements (NVS)

Wires

Forums

Community

Quotes

Stocks

Calendar

Information

Books

Analysis

Novartis shareholders
Novartis Financial Statements (NVS)
Years Quarters US GAAP
Novartissmart-lab.ru	%	2021	2022	2022	2022	2023	LTM ?
Report date		26.04.2022	31.12.2022	01.02.2023	15.05.2023	31.01.2024	30.09.2024
Currency		USD	USD	USD	USD	USD	USD
Financial report URL

Revenue, bln rub	?	52 877	51 828	51 828	51 828	46 660	49 289
Operating Income, bln rub		26 948	9 197	9 197	9 197	9 769	13 766
EBITDA, bln rub	?	33 061	16 389	14 726	16 389	18 286	19 768
Net profit, bln rub	?	24 021	6 955	6 955	6 955	14 850	17 603

OCF, bln rub	?	15 071	14 236	14 236	14 236	14 458	15 973
CAPEX, bln rub	?	2 971	2 671	2 671	2 671	2 753	3 466
FCF, bln rub	?	12 100	11 565	11 565	11 565	11 705	12 507
Dividend payout, bln rub		7 368	7 506	7 506	7 506	7 255	7 624

Ordinary share dividend yield, %		0.00%	0.00%	0.00%	0.00%	0.00%	0
Dividend payout ratio, %		30.7%	107.9%	107.9%	107.9%	48.9%	43.3%

OPEX, bln rub		25 321	27 145	27 145	27 145	24 871	22 920
Cost of production, bln rub		15 867	15 486	15 486	15 486	12 472	12 603
R&D, bln rub		9 540	9 996	9 996	9 996	11 371	9 465
Interest expenses, bln rub		811.0	837.0	837.0	837.0	855.0	948.0

Assets, bln rub		131 795	117 453	117 453	117 453	99 945	103 524
Net Assets, bln rub	?	67 655	59 342	59 342	59 342	46 667	43 317
Debt, bln rub		31 093	27 964	27 964	27 964	26 348	32 159
Cash, bln rub		28 329	18 930	18 930	18 930	14 428	14 020
Net debt, bln rub		2 764	9 034	9 034	9 034	11 920	18 139

Ordinary share price, rub		82.8	90.7	85.9	85.9	101.0	84.0
Number of ordinary shares, mln		2 243	2 181	2 181	2 181	2 077	2 012

Market cap, bln rub		185 620	197 860	187 254	187 254	209 694	169 008
EV, bln rub	?	188 384	206 894	196 288	196 288	221 614	187 147
Book value, bln rub		3 878	-1 603	-1 603	-1 603	-3 553	-9 515

EPS, rub	?	10.7	3.19	3.19	3.19	7.15	8.75
FCF/share, rub		5.40	5.30	5.30	5.30	5.64	6.22
BV/share, rub		1.73	-0.73	-0.73	-0.73	-1.71	-4.73

EBITDA margin, %	?	62.5%	31.6%	28.4%	31.6%	39.2%	40.1%
Net margin, %	?	45.4%	13.4%	13.4%	13.4%	31.8%	35.7%
FCF yield, %	?	6.52%	5.85%	6.18%	6.18%	5.58%	7.40%
ROE, %	?	35.5%	11.7%	11.7%	11.7%	31.8%	40.6%
ROA, %	?	18.2%	5.92%	5.92%	5.92%	14.9%	17.0%

P/E	?	7.73	28.4	26.9	26.9	14.1	9.60
P/FCF		15.3	17.1	16.2	16.2	17.9	13.5
P/S	?	3.51	3.82	3.61	3.61	4.49	3.43
P/BV	?	47.9	-123.4	-116.8	-116.8	-59.0	-17.8
EV/EBITDA	?	5.70	12.6	13.3	12.0	12.1	9.47
Debt/EBITDA		0.08	0.55	0.61	0.55	0.65	0.92

R&D/CAPEX, %		321.1%	374.2%	374.2%	374.2%	413.0%	273.1%

CAPEX/Revenue, %		5.62%	5.15%	5.15%	5.15%	5.90%	7.03%

Have an idea?

Moscow Exchange is the source and the owner of marketdata. The users haven't right of further distribution or presentation of any data without written permission of Moscow Exchange, haven't right to create modified information for further public distribution to third parties.